.

Investment in DEARhealth

AMSTERDAM 18 July 2019 - DEARhealth, a health tech spin-out from the University of California, Los Angeles (UCLA), today announced a first closing of its Series A round with Philips Health Technology Ventures, Vesalius Biocapital III and Health Innovations. DEARhealth offers Artificial Intelligence (AI)-powered health pathways for chronic care.

Schneider-Littfeld in Advisory Board

Munich, 04.07.2019 - The Munich based medical technology startup Mecuris GmbH won industry expert Johannes Schneider Littfeld as Chairman of the Advisory Board. The company Mecuris offers a digital workshop for the creation and individualisation of prostheses and orthoses.

Final Close of EUR 120 million Fund

Luxembourg-Strassen, June 25, 2019 – Vesalius Biocapital III ('Vesalius'), the specialist life sciences venture capital investor, announces the final close of the VBC III fund securing EUR 120 million of equity commitments.

SWORD Health raises $8M funding

New York, Tuesday, 16th April 2019: SWORD Health, a tech-enabled physical therapy provider, has raised $8 million in a series A investment round led by Khosla Ventures and several other prominent angel investors. It will allow SWORD to focus on bringing its technology to more patients' homes and expand its footprint in the U.S. market.

Mecuris: Schindler as brand ambassador

Tuesday, 09 April 2019 – Paralympic cyclist Denise Schindler is new brand ambassador for Medtech startup Mecuris. The Paralympic cyclist and current Vice World Champion will be the face of Mecuris for the next four years.

Forendo: Positive Phase 1a Results

Turku, Finland, March 7th 2019: Forendo Pharma, a clinical stage drug development company focusing on novel treatments in women's health, today announces that it has successfully completed Phase 1a study of its lead program FOR-6219, a novel, tissue specific treatment of endometriosis.

Mecuris GmbH: Financing EUR 3.6m

Wednesday, 16 January 2019 – Mecuris, a commercial stage company, teams up with certified prosthetists and orthotists (CPOs) to move orthopaedic care into the digital age.

Vesalius Biocapital III Partners joins Forendo Pharma Investor Syndicate

Wednesday, 5 September 2018 – Forendo Pharma today announces that it has raised an additional €4 million of funding from Vesalius Biocapital III Partners.

SWORD Health secures $4.6 million in seed funding

Monday, 16 April 2018 – SWORD Health, the creator of the AI-powered digital physiotherapist SWORD Phoenix, announces the close of its $4.6 million seed funding round.

Vesalius Biocapital Launches New Fund in Collaboration with Portuguese National Promotional Bank (IFD)

Tuesday, 19 September 2017 – First international investment by IFD. New fund will focus on investing in Portuguese life science companies

.

xxnoxx_zaehler